TR200605624A2 - Farmasötik dozaj şekli - Google Patents

Farmasötik dozaj şekli

Info

Publication number
TR200605624A2
TR200605624A2 TR2006/05624A TR200605624A TR200605624A2 TR 200605624 A2 TR200605624 A2 TR 200605624A2 TR 2006/05624 A TR2006/05624 A TR 2006/05624A TR 200605624 A TR200605624 A TR 200605624A TR 200605624 A2 TR200605624 A2 TR 200605624A2
Authority
TR
Turkey
Prior art keywords
dosage form
core tablet
pharmaceutical dosage
enteric coating
pantoprazole
Prior art date
Application number
TR2006/05624A
Other languages
English (en)
Inventor
Uslu Abdullah
Original Assignee
Nobel İlaç Sanayi̇ Ve Ti̇caret Aş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobel İlaç Sanayi̇ Ve Ti̇caret Aş. filed Critical Nobel İlaç Sanayi̇ Ve Ti̇caret Aş.
Priority to TR2006/05624A priority Critical patent/TR200605624A2/tr
Priority to PCT/TR2007/000121 priority patent/WO2008045009A2/en
Priority to EP07852324A priority patent/EP2086517A2/en
Publication of TR200605624A2 publication Critical patent/TR200605624A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pantoprazol etkin maddesini içeren buluş konusu farmasötik katı dozaj şekli bir çekirdek tableti, bir enterik kaplamayı ve çekirdek tablet ile enterik kaplama arasında bulunan bir ön kaplamayı içermektedir. Çekirdek tablet, pantoprazol etkin maddesi dışında bağlayıcı olarak sodyum karboksimetilselüloz ve dolgu maddesi olarak isomalt içermektedir.
TR2006/05624A 2006-10-10 2006-10-10 Farmasötik dozaj şekli TR200605624A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2006/05624A TR200605624A2 (tr) 2006-10-10 2006-10-10 Farmasötik dozaj şekli
PCT/TR2007/000121 WO2008045009A2 (en) 2006-10-10 2007-10-10 Pharmaceutical dosage form
EP07852324A EP2086517A2 (en) 2006-10-10 2007-10-10 Pharmaceutical dosage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2006/05624A TR200605624A2 (tr) 2006-10-10 2006-10-10 Farmasötik dozaj şekli

Publications (1)

Publication Number Publication Date
TR200605624A2 true TR200605624A2 (tr) 2008-05-21

Family

ID=39283297

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2006/05624A TR200605624A2 (tr) 2006-10-10 2006-10-10 Farmasötik dozaj şekli

Country Status (3)

Country Link
EP (1) EP2086517A2 (tr)
TR (1) TR200605624A2 (tr)
WO (1) WO2008045009A2 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105380919A (zh) * 2015-11-20 2016-03-09 世贸天阶制药（江苏）有限责任公司 一种泮托拉唑钠肠溶片及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
DE19752843C2 (de) * 1997-11-28 2003-01-09 Byk Gulden Lomberg Chem Fab Arzneimittelzubereitung in Tabletten- oder Pelletform für Pantoprazol und Omeprazol
GB0003782D0 (en) * 2000-02-17 2000-04-05 Dumex Ltd As Process

Also Published As

Publication number Publication date
EP2086517A2 (en) 2009-08-12
WO2008045009A2 (en) 2008-04-17
WO2008045009A3 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
DK3103448T3 (da) Farmaceutiske sammensætninger, der omfatter en S1P-modulator
EA201290984A1 (ru) Гелеобразные фармацевтические композиции, препятствующие злоупотреблению
CR20110110A (es) Composicion farmaceutica
BR112012024139A2 (pt) formulações farmacêuticas de camada dupla contendo agonistas e antagonistas de opióide.
CL2009000903A1 (es) Composiciones farmacéuticas que comprenden un núcleo que contiene una droga débilmente básica seleccionada de derivados de butirofenona, una capa de amortiguador de ph alcalino y un recubrimiento de liberación controlada, método para preparar dichas composiciones y formas de dosificación farmacéutica que las incluyen.
BRPI0917693A2 (pt) composto derivado de triazol, composição farmacêutica, e, uso de um derivado de triazol
FR2949062B1 (fr) Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
WO2009117130A3 (en) Extended release forumulation containing a wax
IL197933A (en) Knaase inhibitors, pharmaceuticals containing them and their uses
SI2395002T1 (sl) Farmacevtski sestavek, vsebujoč heterociklični modulator prenašalcev z ATP-vezavno kaseto
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
EA021377B9 (ru) Модуляторы толл-подобных рецепторов
WO2014002058A3 (en) Complement pathway modulators and uses thereof
MX375936B (es) Composiciones farmaceuticas mejoradas de pimobendan.
EA201491658A1 (ru) Таблетки для комбинированной терапии
WO2008129517A3 (en) A stabilized delayed release pharmaceutical composition of rabeprazole
AU2012347200A8 (en) Tablet capable of combatting misuse by injection
TW200806282A (en) Solid dosage formulations
EA201101596A1 (ru) Композиция для непрерывной доставки лекарственного средства, содержащая геополимерное связующее
WO2007090661A3 (en) Active substance combination comprising azolylcarbinol compounds
PH12014501408A1 (en) Immediate release multi unit pellet system
UY31452A1 (es) Recubrimiento mejorado de tableta
EP1584335A3 (en) Active substance combination comprising a carbinol composition and an opioid
TR200604349A2 (tr) Aripiprazol içeren farmasötik bileşimler
WO2013188465A3 (en) Treating drug addiction and preventing drug relapse